D-0002-2026 Class II Ongoing
FDA drug recall D-0002-2026 was initiated by Zydus Pharmaceuticals (USA) Inc on Sep 24, 2025 and is designated Class II. Reason for recall: Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity The recall status is ongoing. Affected quantity: 600 30-count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 8, 2025
- Initiation Date
- Sep 24, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 600 30-count bottles
Product description
Entecavir Tablets, USP, 1 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-921-06.
Reason for recall
Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity
Distribution pattern
Distributed Nationwide in the USA
Code information
Lot#: E409309, Exp 12/31/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0002-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026